Belgium· BE-AMP-SAM233721-00
Ceprotin 500 IU
A protein c product containing protein c, registered in Belgium by Takeda Manufacturing Austria. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Protein c is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AD12 (protein c), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Protein c · ATC B01AD12
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Protein C
- Manufacturer
- Takeda Manufacturing Austria
- Country
- Belgium (BE)
- ATC code
- B01AD12
- ATC class
- Protein C
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0773051
- be_apb1756915
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for protein c.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Protein c · interactions on record
34 records
- 1 severe
- 33 moderate
Most severe, free to view
- CaplacizumabB01AX07severe
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Protein c in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCeprotin 500 IE Pulver och vätska till injektionsvätska, lösningTakeda Manufacturing Austria AG
- FranceCEPROTIN 1000 UI/10 ml, poudre et solvant pour solution injectableTAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- SwitzerlandCeprotin 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaCEPROTINTakeda Manufacturing Austria AG, Vídeň
- FinlandCeprotinBaxter AG
- United KingdomCeprotin 1000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandCeprotinBaxter Vaccine AG
- IcelandCeprotinBaxter AG*
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Protexel
- Iceland · Ceprotin
- Liechtenstein · Ceprotin
- Norway · Ceprotin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59c81aa0-33d6-4fa7-aa52-a36e70b34b78 GET /v1/drugs/59c81aa0-33d6-4fa7-aa52-a36e70b34b78?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Ceprotin 500 IU",
"name_fr": "Ceprotin 500 IU",
"name_nl": "Ceprotin 500 IU",
"amp_code": "SAM233721-00",
"strengths": [
"100.0000",
"100.0000",
"44.0000"
],
"pack_count": 1,
"substances": [
"Protein C",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Protein C",
"authorisation_numbers": [
"EU/1/01/190/001"
]
}See everything about protein c.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.